PPH holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 100% at a quoted market price (level 1), 9 issuer countries.

PPH's largest investment is Eli Lilly & Co at 20.23% of net assets. Novartis AG and Merck & Co Inc follow; the three together are 40.7%. Ten companies are 73.08% of the fund; the other 15 share the rest. Among the 721 equity funds measured here, PPH behaves like 11.7 holdings against a median of 42.4 — 3.6 times more concentrated than the median. Across 28 quarterly filings PPH has become more concentrated: it behaved like 22.4 at 2019-09-30 and 11.7 at 2026-06-30. the United States is the largest country at 60.91% of the portfolio, across 9 countries in the filing.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-09-30 and 2026-06-30, PPH went from behaving like 22.4 equally weighted positions to 11.7 — 48% fewer, while its top ten went from 51.96% to 73.08% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

The 15 largest of 25 positions in PPH's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: PPH.csv.gz.

Share of PPH's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of PPH's own filings, 84 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: PPH.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-06-30, $63m was out to 6 borrowers, 7.11% of net assets. The largest, BNP PARIBAS PRIME BROKERAGE INTERNATIONAL LIMITED, held 55.7% of it.

Cash collateral reported against the loan: 0.28% of net assets, 3.9% of the amount lent. That is a floor on the collateral, not the whole of it — collateral the fund does not hold as a position is not in this filing, so a figure under 100% is not evidence of under-collateralisation. How that figure behaves across all funds. Every quarter PPH has filed, with each borrower: PPH.json · all funds.

25 positions became 25: 0 added (0.0% of the fund at the later date), 0 dropped (0.0% at the earlier date). Half the sum of all weight changes, a turnover proxy: 4.2%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of PPH compared this way, as a feed: changes.xml · all funds: filings received.

99.72% equity, 0.28% short-term investment as filed; 100.0% carried at a quoted market price (fair-value level 1). Categories and levels are the filer's; what a low level-1 share does and does not mean is in the measure's page.

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of PPH (11.7). Same filings, same arithmetic. Position in this list says nothing about which fund is better.